Security key
22663K107
Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX)
CUSIP: 22663K107
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 105,000,216
- Total 13F shares
- 51,456,378
- Share change
- +729,635
- Total reported value
- $1,010,816,996
- Price per share
- $19.64
- Number of holders
- 118
- Value change
- +$16,147,822
- Number of buys
- 65
- Number of sells
- 39
Report period
Q3 2022
Institutions
118
Top holders
10
CRNX full security history
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Crinetics Pharmaceuticals, Inc. SEC filings
Crinetics Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22663K107
Recent filing periods:
Top shareholders of CRNX - Crinetics Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
5.2%
|
5,474,459
|
$102,099,000 | — | 30 Jun 2022 | |
| PERCEPTIVE ADVISORS LLC |
3/4/5
13F
|
10%+ Owner · Company |
5.1%
from 13F
|
5,321,032
|
$200,336,855 | — | 18 Apr 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.6%
|
3,789,483
|
$70,675,000 | — | 30 Jun 2022 | |
| BVF INC/IL |
13F
|
Company |
3.5%
|
3,678,947
|
$68,612,000 | — | 30 Jun 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
3%
|
3,196,876
|
$59,622,000 | — | 30 Jun 2022 | |
| FMR LLC |
13F
|
Company |
2.8%
|
2,987,020
|
$55,707,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
2,444,514
|
$45,590,000 | — | 30 Jun 2022 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
2.2%
|
2,305,558
|
$42,999,000 | — | 30 Jun 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.7%
|
1,823,598
|
$34,010,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.7%
|
1,760,845
|
$32,840,000 | — | 30 Jun 2022 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.3%
|
1,414,823
|
$26,386,000 | — | 30 Jun 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.3%
|
1,332,800
|
$24,857,000 | — | 30 Jun 2022 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.3%
|
1,330,263
|
$24,809,000 | — | 30 Jun 2022 | |
| First Light Asset Management, LLC |
13F
|
Company |
1.2%
|
1,240,609
|
$23,137,000 | — | 30 Jun 2022 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
1,125,112
|
$20,983,000 | — | 30 Jun 2022 | |
| Deep Track Capital, LP |
13F
|
Company |
1%
|
1,053,000
|
$19,638,000 | — | 30 Jun 2022 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.82%
|
862,286
|
$16,082,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.81%
|
850,938
|
$15,869,000 | — | 30 Jun 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.79%
|
827,480
|
$15,433,000 | — | 30 Jun 2022 | |
| Opaleye Management Inc. |
13F
|
Company |
0.64%
|
671,300
|
$12,520,000 | — | 30 Jun 2022 | |
| Novo Holdings A/S |
13F
|
Company |
0.6%
|
631,627
|
$11,780,000 | — | 30 Jun 2022 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.56%
|
586,820
|
$10,944,000 | — | 30 Jun 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.53%
|
553,871
|
$10,329,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.49%
|
509,330
|
$9,499,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.46%
|
484,281
|
$9,032,000 | — | 30 Jun 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.38%
|
402,010
|
$7,498,000 | — | 30 Jun 2022 | |
| MPM BioImpact LLC |
13F
|
Company |
0.35%
|
366,676
|
$6,839,000 | — | 30 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.32%
|
331,671
|
$6,186,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.32%
|
331,245
|
$6,177,000 | — | 30 Jun 2022 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.2%
|
205,100
|
$3,825,000 | — | 30 Jun 2022 | |
| Walleye Capital LLC |
13F
|
Company |
0.15%
|
154,092
|
$2,874,000 | — | 30 Jun 2022 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.14%
|
152,200
|
$2,838,000 | — | 30 Jun 2022 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
0.13%
|
141,000
|
$2,630,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.13%
|
139,616
|
$2,605,000 | — | 30 Jun 2022 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
139,539
|
$2,602,000 | — | 30 Jun 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.12%
|
129,800
|
$2,421,000 | — | 30 Jun 2022 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.11%
|
110,278
|
$2,057,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
97,453
|
$1,817,000 | — | 30 Jun 2022 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.09%
|
95,000
|
$1,772,000 | — | 30 Jun 2022 | |
| Swiss National Bank |
13F
|
Company |
0.08%
|
88,000
|
$1,641,000 | — | 30 Jun 2022 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.08%
|
87,460
|
$1,631,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.08%
|
86,400
|
$1,611,000 | — | 30 Jun 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.08%
|
84,624
|
$1,578,000 | — | 30 Jun 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
73,556
|
$1,372,000 | — | 30 Jun 2022 | |
| Atom Investors LP |
13F
|
Company |
0.06%
|
58,601
|
$1,093,000 | — | 30 Jun 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.05%
|
54,407
|
$1,015,000 | — | 30 Jun 2022 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.05%
|
54,338
|
$1,013,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
54,285
|
$1,013,000 | — | 30 Jun 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.05%
|
51,200
|
$955,000 | — | 30 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
49,966
|
$932,000 | — | 30 Jun 2022 |
Institutional Holders of Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX) as of Q3 2022
As of 30 Sep 2022,
Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX) was held by
118 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,456,378 shares.
The largest 10 holders included
DRIEHAUS CAPITAL MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., BVF INC/IL, ORBIMED ADVISORS LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Bain Capital Life Sciences Investors, LLC, and STATE STREET CORP.
This page lists
118
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
109
Q3 2022 holders
118
Holder diff
9
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.